deficiencies. The overall Ca 2 þ balance is maintained by the concerted action of Ca 2 þ absorption in the intestine, reabsorption in the kidney, and exchange from bone, which are all under the control of the calciotropic hormones that are released upon a demand for Ca 2 þ . In the kidney, these calciotropic hormones affect active Ca 2 þ reabsorption, which consists of TRPV5 as the apical entry gate for Ca 2 þ influx, calbindin-D 28K as an intracellular ferry for Ca 2 þ and, NCX1 and PMCA1b for extrusion of Ca 2 þ across the basolateral membrane. This review highlights the action of hormones on renal Ca 2 þ handling and focuses on the coordinated control of the renal Ca 2 þ transport proteins. Parathyroid hormone stimulates renal Ca 2 þ handling by regulating active Ca Ion homeostasis in our body is tightly regulated and disturbances in its balance may lead to pathogenesis. The kidney plays a vital role in this process by balancing the dietary intake with the reabsorption from the pro-urine. One of these ions is Ca 2 þ that plays a key role in many physiological processes like hormone secretion, muscle contraction, bone formation, nerve conduction, exocytosis, and (in)activation of enzymes. The body, therefore, carefully regulates the plasma concentration of Ca 2 þ within a narrow range by the concerted action of intestinal Ca 2 þ absorption, exchange of Ca 2 þ from bone and renal Ca 2 þ reabsorption. An intrinsic physiological mechanism is sensing the Ca 2 þ demand by a specialized Ca 2 þ -sensing receptor that activates a cascade of pathways, eventually leading to the synthesis and release of calciotropic hormones, including 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), parathyroid hormone (PTH) and calcitonin. These hormones act in a paracrine fashion, efficiently regulating the above-described Ca 2 þ transport processes. In the kidney, Ca 2 þ can re-enter the blood by paracellular (passive) as well as transcellular (active) Ca 2 þ reabsorption and the latter is the main target for the calciotropic hormones. Active Ca 2 þ reabsorption comprises a sequence of processes restricted to the distal convoluted tubule (DCT) and the connecting tubule (CNT). At the cellular level, Ca 2 þ enters the renal epithelial cell via the highly Ca 2 þ -selective channel TRPV5 because of a steep inward electrochemical gradient across the apical membrane. In the cell, Ca 2 þ is bound to calbindin-D 28K that ferries Ca 2 þ from the apical side to the basolateral side where the Na þ /Ca 2 þ -exchanger (NCX1) and the plasma membrane ATPase (PMCA1b) extrude Ca 2 þ into the blood compartment ( Figure 1 ). In the intestine, a similar mechanism for transcellular Ca 2 þ absorption occurs with TRPV6 as the gatekeeper, calbindin-D 9K as intracellular ferry of Ca 2 þ and PMCA1b as the extrusion mechanism. This review highlights the hormonal regulation of Ca 2 þ reabsorption in the kidney and focuses on the coordinated expression of the Ca 2 þ transport proteins TRPV5, calbindin-D 28K , NCX1, and PMCA1b as the underlying mechanism contributing to the Ca 2 þ balance.
RENAL Ca 2 þ HANDLING AND PTH
Primary hyperparathyroidism is characterized by PTH levels that are inappropriate to the level of plasma Ca 2 þ and is one of the endocrine disorders that underline the importance of PTH in maintaining the Ca 2 þ balance. In addition, mutations in the Ca 2 þ -sensing receptor, which couples the plasma Ca 2 þ levels to the production and secretion of PTH from the thyroid glands, were identified in patients with familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism (inactivating mutations), 1 and autosomaldominant hypocalcemia (activating mutations). 2 From the clinical symptoms of these PTH-related disorders, including hypo-or hypercalciuria and renal stone formation, it is evident that renal Ca 2 þ handling is also affected. PTH receptors have been detected throughout the nephron including DCT and CNT, thus enabling the body to directly control active Ca 2 þ reabsorption in the kidney via PTH. 3 In addition, genetic ablation of Ca 2 þ -sensing receptor resulted in hyperparathyroidism and hypercalcemia, accompanied by an upregulation of TRPV5 and TRPV6 in the kidney and intestine, respectively (Table 1) . 4 To understand the molecular regulation of the Ca 2 þ transport proteins by PTH, parathyroidectomy was performed in rats. 5 The effectiveness of this treatment was evident from the marked reduction of PTH levels and hyperphosphatemia, a well-known symptom in hypoparathyroidism. Moreover, parathyroidectomy reduced the expression of TRPV5, calbindin-D 28K , and NCX1. This decline in expression of the renal Ca 2 þ transport proteins resulted in decreased active Ca 2 þ reabsorption and the development of hypocalcemia. PTH supplementation in these parathyroidectomized rats resulted in normalization of the renal Ca 2 þ transport protein expression levels and increased the plasma Ca 2 þ concentration. 5 In addition, the regulation by PTH was investigated in primary cultures of rabbit CNT and cortical collecting duct (CCD) cells. 
Estrogens Estrogen receptor-a
Overview of the different studies investigating the expression of the Ca 2+ transport proteins in the kidney and intestine. 8 Thus, besides a genomic effect, PTH can stimulate Ca 2 þ reabsorption directly via a short-term mechanism involving protein kinase A and protein kinase C. Taken together, these studies reveal that PTH-dependent stimulation of transcellular Ca 2 þ reabsorption in the kidney occurs via both genomic and nongenomic pathways.
RENAL Ca 2 þ HANDLING AND ESTROGENS
An increased risk for osteoporosis in postmenopausal women is associated with estrogen deficiency. Furthermore, estrogen deficiency is associated with renal Ca 2 þ wasting and intestinal Ca 2 þ malabsorption that can be restored by estrogen replacement therapy. 9 From these findings, the physiological relevance of estrogens in maintaining the Ca 2 þ balance is feasible. In addition, this suggests that estrogens can comply with the action of the calciotropic hormones, regulating the expression of the renal Ca 2 þ transport proteins. Estrogen receptors have been detected in DCT and CNT, thus enabling the body to directly regulate active Ca 2 þ reabsorption in the kidney by estrogen. 3 Estrogen replacement therapy in ovariectomized rats revealed an increase in the expression of TRPV5, calbindin-D 28K , NCX1, and PMCA1b in the kidney suggesting an important role for this hormone in regulating Ca 2 þ reabsorption. 3 In addition, genetic ablation of the estrogen receptor-a in mice decreased the expression of the aforementioned renal Ca 2 þ transport proteins. In principle, these effects could be explained by estrogen-dependent vitamin D activation. This possibility was investigated in vitamin D-deficient animal models. Estrogen supplementation in 25-hydroxyvitamin D 3 -1a-hydroxylase (1a-OHase) knockout mice increased the expression of TRPV5 in the kidney, whereas the expression of the other Ca 2 þ transport proteins remained unaltered. 3 In the intestine, estrogens regulate the expression of TRPV6 in a vitamin D-independent manner, which became clear from estrogen supplementation in vitamin D receptor and 1a-OHase knockout mice. This resulted in an upregulation of duodenal TRPV6, whereas the expression of calbindin-D 9K and PMCA1b was not altered. 3 Thus, estrogens harbor calciotropic hormone characteristics regulating the expression of TRPV5 and TRPV6 in the kidney and intestine, respectively. Strikingly, microarray analysis of 1,25(OH) 2 D 3 -stimulated carcinoma cells revealed TRPV6 as one of the most highly vitamin D-responsive genes. 13 Evidence for 1,25(OH) 2 D 3 -controlled expression of the renal Ca 2 þ transport proteins came from rats that were raised on a vitamin D-deficient diet. This diet decreased the renal expression of TRPV5, which was accompanied by a marked drop in plasma Ca 2 þ levels. In addition, genetic ablation of 1a-OHase in mice resulted in severe hypocalcemia, hyperparathyroidism, bone abnormalities, and retarded growth.
RENAL
14 In line with the development of hypocalcemia is the diminished Ca 2 þ reabsorption in the kidney, presumably as a result of the downregulated expression of the Ca 2 þ transport proteins TRPV5, calbindin-D 28K , and NCX1. handling independent of vitamin D. From a molecular point of view, dietary Ca 2 þ affects the Ca 2 þ balance by regulating the expression of the renal and intestinal Ca 2 þ transport proteins. This is evident from high dietary Ca 2 þ supplementation in mice which, among others, resulted in a decreased TRPV5 and TRPV6 expression. 3 This decline in expression is likely mediated by the accompanied decrease in 1,25(OH) 2 D 3 levels. However, in 1a-OHase knockout mice a high dietary Ca 2 þ load normalized the plasma Ca 2 þ concentration as well as the expression of TRPV5, calbindin-D 28K , NCX1, and PMCA1b. 3 Likewise, in mice that lack vitamin D receptor an increased dietary Ca 2 þ intake upregulates the expression of TRPV5 in the kidney. 17 In addition, the expression of TRPV6 in the intestine was increased. Taken together, dietary Ca 2 þ regulates the expression of the Ca 2 þ transport proteins, independent of 1,25(OH) 2 19 Besides calmodulin, the Ca 2 þ -binding protein calcineurin/nuclear factor of activated T cells signaling pathway can also stimulate gene expression upon a rise of intracellular Ca 2 þ and recently this pathway has been shown to be essential for the expression of the sodium-phosphate co-transporter (NaP i ) in the kidney. 20 Currently, it is not known whether these pathways are involved in renal TRPV5-mediated Ca 2 þ signaling. To further identify gene products in the kidney that are regulated by high dietary Ca 2 þ and/or 1,25(OH) 2 D 3 , cDNA microarray analysis was performed on kidneys from high dietary Ca 2 þ or 1,25(OH) 2 D 3 -treated 1a-OHase knockout mice. In this study, 1,25(OH) 2 D 3 induced a significant regulation of B1000 genes, whereas dietary Ca 2 þ supplementation of the 1a-OHase knockout mice revealed B2000 controlled genes. 3 Importantly, Ca 2 þ transport proteins including NCX1 and calbindin-D 28K were among the dietary Ca 2 þ regulated genes. This confirms previous findings that besides vitamin D, dietary Ca 2 þ regulates the expression of the renal Ca 2 þ transport proteins. Furthermore, intracellular signaling molecules, including calmodulin, were identified that might be part of the signaling pathway that underlie the Ca 2 þ regulated expression in the kidney. Further research is, however, needed to establish a comprehensive molecular mechanism underlying the Ca 2 þ -dependent genomic regulation of the renal Ca 2 þ transport proteins.
CONCLUSION
Regulation of the renal Ca 2 þ transport proteins TRPV5, calbindin-D 28K , NCX1, and PMCA1b, which determine the net active flux of Ca 2 þ to the blood compartment, is of physiological importance to maintain the Ca 2 þ balance. We have presented an overview of the current knowledge concerning the hormonal regulation of renal Ca 2 þ handling and focused on the mechanism of coordinated control of the renal Ca 2 þ transport proteins. These findings constitute the mechanism of regulating active Ca 2 þ reabsorption in the kidney via TRPV5. Once the activity of the gatekeeper TRPV5 is altered, the complete Ca 2 þ transport machinery will be affected accordingly, as the magnitude of the Ca 2 þ flux that enters the cell via TRPV5 coordinates the expression of the other Ca 2 þ transport proteins. The underlying molecular signaling pathway, however, remains to be identified. Future studies like promoter analysis in the Ca 2 þ transporter genes to identify Ca 2 þ -responsive elements, and experiments focusing on the different Ca 2 þ -dependent signaling pathways will bring further knowledge about the Ca 2 þ -regulated coordinated control of renal Ca 2 þ transporters. From a clinical point of view, these findings reveal an efficient way to regulate overall renal Ca 2 þ handling by compounds that specifically stimulate or inhibit the gatekeeper TRPV5.
